Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus.
Journal: 2003/July - The Lancet
ISSN: 1474-547X
PUBMED: 12814717
Abstract:
The outbreak of SARS warrants the search for antiviral compounds to treat the disease. At present, no specific treatment has been identified for SARS-associated coronavirus infection. We assessed the antiviral potential of ribavirin, 6-azauridine, pyrazofurin, mycophenolic acid, and glycyrrhizin against two clinical isolates of coronavirus (FFM-1 and FFM-2) from patients with SARS admitted to the clinical centre of Frankfurt University, Germany. Of all the compounds, glycyrrhizin was the most active in inhibiting replication of the SARS-associated virus. Our findings suggest that glycyrrhizin should be assessed for treatment of SARS.
Relations:
Citations
(171)
Clinical trials
(1)
Diseases
(1)
Drugs
(1)
Chemicals
(3)
Organisms
(4)
Processes
(1)
Anatomy
(1)
Affiliates
(2)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.